Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. März 2026 16:25 ET | Quelle: Calidi Biotherapeutics, Inc

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA through Type D interactions, and the Company believes its...
27. März 2026 14:30 ET | Quelle: Hagens Berman Sobol Shapiro LLP

QURE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data

Investors who lost money in QURE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
27. März 2026 13:00 ET | Quelle: Monopar Therapeutics Inc.

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative...
27. März 2026 10:59 ET | Quelle: The Gross Law Firm

CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics Incorporated Securities Class Action Lawsuit — The Gross Law Firm

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Corcept Therapeutics Incorporated (NASDAQ: CORT). Shareholders who purchased shares of...
27. März 2026 10:55 ET | Quelle: Research and Markets

Vulvar Cancer Market Size to Grow by $270 Million During 2026-2030: Investments and Personalized Medicine Drive Market Expansion

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Vulvar Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering.The vulvar cancer market has seen significant growth and is...
27. März 2026 07:52 ET | Quelle: Lexlegis

Lexlegis Showcases Legal AID at NVIDIA GTC 2026; Announces U.S. Beta Launch, Signals Rise of the ‘Legal Intelligence Factory’

SAN JOSÉ, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Lexlegis, an AI-first legal technology company, marked a significant global milestone at NVIDIA GTC 2026, unveiling its advanced legal AI...
27. März 2026 06:00 ET | Quelle: MEXC Ventures

MEXC Ventures Supports Industry Dialogue and Ecosystem Collaboration at NBX 2026

MEXC Ventures joined Next Block Expo (NBX) 2026 as Gold Sponsor in Warsaw, Poland, co-hosting an exclusive Michelin-level VIP dinner with NBX.
26. März 2026 22:05 ET | Quelle: FlightPath

FlightPath Golf Tees Get Reviewed for Effective Accuracy and Distance - Results Inside

Patented polycarbonate golf tee design examined for backspin reduction, ball flight consistency, and durability. 2026 FlightPath Golf overview.
26. März 2026 17:10 ET | Quelle: LeonaBio, Inc.

LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update

Acquired License to Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator (SERM), a Potential Multi-Billion Dollar Opportunity as Treatment Option for Breast Cancer...
26. März 2026 16:05 ET | Quelle: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a Marketing Authorization Application (MAA) to Brazil’s National Health...

Vorherige Seite